Product category:
Chromatographs: gas
News Release from: Agilent Technologies Europe
Edited by the Laboratorytalk Editorial
Team on 13 October 2003
Researching the basic mechanisms of
heart disease
Top scientific researchers apply gene-expression techniques to improve prevention, diagnosis and treatment of leading cause of deaths
Agilent Technologies has announced a multi-year research agreement with the Donald Reynolds Cardiovascular Clinical Research Center at Stanford University designed to help deliver better care for heart disease Scientists at Stanford and Agilent Laboratories are applying Agilent's gene-expression technologies and computational expertise to analyse cardiovascular tissue samples from human patients
This article was originally published on Laboratorytalk on 30 Jun 2008 at 8.00am (UK)
Related stories
Agilent updates CGH microarray software
For large-scale experiments, Agilent DNA Analytics 4.0 can process more than 100 microarrays (244K), helping users easily compare data and visualise patterns
Agilent upgrades EZChrom Elite for China and Japan
The software is now localised into Chinese and Japanese, features a single walk-up sample entry screen and offers updated workstation compliance
The goal is to identify, characterise and validate potential diagnostic and drug targets that could significantly enhance the prevention, diagnosis and treatment of heart disease, the leading cause of death in the United States.
Agilent Labs is the central research facility of Agilent Technologies.
The Reynolds Center was established at Stanford in 2000.
Further reading
New standard for validating machine-tool accuracy
Agilent Technologies has introduced its new 5530 Dynamic Calibrator, a laser-based calibration system for measuring machine-tool and coordinate-measuring-machine (CMM) accuracy
High-res scanner for current, next-gen microarrays
Agilent Technologies latest version DNA Microarray Scanner employs SureScan high resolution technology to deliver high resolution and rapid scan times for current and next-generation microarrays
The two research groups are using advanced molecular-biology techniques and tools, including Agilent's DNA microarray platform and custom arrays, to identify genes and gene-expression patterns associated with heart disease.
"Collaborating with Agilent Labs gives us access to a DNA microarray platform that provides leading-edge sensitivity and reproducibility, as well as accomplished molecular biologists who help us optimize our gene-expression experiments," said Thomas Quertermous, the William Irwin Professor and chief of research in Stanford's division of cardiovascular medicine.
"Access to Agilent Labs' leading-edge computational experts and tools helps us to rapidly interpret the data from tens of thousands of genes simultaneously as they interact to produce heart disease.
"This enables the results to be delivered to clinicians and heart patients much more quickly.
"Agilent's ability to provide microarrays with customised gene content offers researchers the opportunity to discover potential functions of both known genes and previously uncharacterised genes as they relate to specific disease processes".
By collaborating with the Reynolds Center at Stanford, Agilent Labs develops a clear understanding of how deep experts in cardiology discover cardiovascular disease mechanisms, including the issues they face when working with real patient samples such as heart and vascular tissue.
"Collaborative research between Agilent Labs and leading research centers such as the Reynolds Center at Stanford places the Labs at the forefront of life sciences innovation," said Darlene Solomon, vice president and director of Agilent Labs.
"This collaboration provides Agilent Labs with an in-depth understanding of the cardiovascular researcher's microarray needs and allows us to explore future uses of microarrays for diagnostic applications - and, thus, better ways to improve patient care.".
• Agilent Technologies Europe: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

